{"title":"Balance between new treatment opportunities and public health expenditure control: The Regulatory Agency role","authors":"C. Tomino","doi":"10.3233/PPL-2010-0286","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":348240,"journal":{"name":"Pharmaceuticals, policy and law","volume":"126 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceuticals, policy and law","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/PPL-2010-0286","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}